exploring challenges with car t cells and nk cells in multiple myeloma
Published 3 years ago • 162 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
0:53
car t cells in the treatment landscape of multiple myeloma
-
1:32
challenges with car t-cell therapy
-
23:40
car t-cells in multiple myeloma
-
49:59
car t-cell therapy: multiple myeloma
-
7:13
treating relapsed/refractory multiple myeloma with car t-cell therapy
-
2:01
allocars and car-nk cells in myeloma
-
1:19
car-t vs car-nk for myeloma
-
0:54
dr. costa on remaining challenges with car t-cell therapy in multiple myeloma
-
1:45
car t-cells in myeloma: patients’ perspective
-
1:00
dr. smith discusses car t cells in multiple myeloma
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
1:13
challenges of dual-targeted car t-cell therapy
-
1:10
combinatorial car-t approaches being explored in multiple myeloma
-
3:52
is car t-cell therapy being used to treat newly diagnosed multiple myeloma?
-
19:39
t-cell engagers: targets, challenges and opportunity
-
9:48
the use of car t-cells in multiple myeloma
-
1:19
dr. munshi on the current landscape of car t-cell therapy in multiple myeloma